GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Newland Pharmaceutical Co Ltd (SZSE:301277) » Definitions » Deferred Policy Acquisition Costs

Newland Pharmaceutical Co (SZSE:301277) Deferred Policy Acquisition Costs


View and export this data going back to 2022. Start your Free Trial

What is Newland Pharmaceutical Co Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Newland Pharmaceutical Co (SZSE:301277) Business Description

Traded in Other Exchanges
N/A
Address
East side of the south section of Weiwu Road, Henan Province, Changge, CHN, 461500
Newland Pharmaceutical Co Ltd is engaged in the research and development, production and sales of chiral pharmaceutical intermediates.